Literature DB >> 10708819

Motor and cognitive aspects of motor retardation in depression.

M P Caligiuri1, J Ellwanger.   

Abstract

BACKGROUND: Motor retardation is a common feature of major depressive disorder having potential prognostic and etiopathological significance. According to DSM-IV, depressed patients who meet criteria for psychomotor retardation, must exhibit motor slowing of sufficient severity to be observed by others. However, overt presentations of motor slowing cannot distinguish slowness due to cognitive factors from slowness due to neuromotor disturbances.
METHODS: We examined cognitive and neuromotor aspects of motor slowing in 36 depressed patients to test the hypothesis that a significant proportion of patients exhibit motor programming disturbances in addition to psychomotor impairment. A novel instrumental technique was used to assess motor programming in terms of the subject's ability to program movement velocity as a function of movement distance. A traditional psychomotor battery was combined with an instrumental measure of reaction time to assess the cognitive aspects of motor retardation.
RESULTS: The depressed patients exhibited significant impairment on the velocity scaling measure and longer reaction times compared with nondepressed controls. Approximately 40% of the patients demonstrated abnormal psychomotor function as measured by the traditional battery; whereas over 60% exhibited some form of motor slowing as measured by the instruments. Approximately 40% of the patients exhibited parkinsonian-like motor programming deficits. A five-factor model consisting of motor measures predicted diagnosis among bipolar and unipolar depressed patients with 100% accuracy. LIMITATIONS: The ability of motor measures to discriminate bipolar from unipolar patients must be viewed with caution considering the relatively small sample size of bipolar patients.
CONCLUSIONS: These findings suggest that a subgroup of depressed patients exhibit motor retardation that is behaviorally similar to parkinsonian bradykinesia and may stem from a similar disruption within the basal ganglia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708819     DOI: 10.1016/s0165-0327(99)00068-3

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  50 in total

1.  Mind and movement: the neuropsychiatry of movement disorders.

Authors:  Belinda R Lennox; Graham G Lennox
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

2.  Internally vs. externally triggered movements in patients with major depression.

Authors:  Felix Hoffstaedter; Jan Sarlon; Christian Grefkes; Simon B Eickhoff
Journal:  Behav Brain Res       Date:  2011-11-28       Impact factor: 3.332

Review 3.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

Review 4.  Use of a physiological profile to document motor impairment in ageing and in clinical groups.

Authors:  S R Lord; K Delbaere; S C Gandevia
Journal:  J Physiol       Date:  2015-12-07       Impact factor: 5.182

Review 5.  Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Authors:  J D Salamone; M Correa; A Farrar; S M Mingote
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

Review 6.  Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.

Authors:  Jennifer C Felger; Michael T Treadway
Journal:  Neuropsychopharmacology       Date:  2016-08-02       Impact factor: 7.853

7.  Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing.

Authors:  Andrew M Farrar; Mariana Pereira; Francisco Velasco; Jörg Hockemeyer; Christa E Müller; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

8.  Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression.

Authors:  Ulrich Hegerl; Roland Mergl; Verena Henkel; Oliver Pogarell; Florian Müller-Siecheneder; Thomas Frodl; Georg Juckel
Journal:  Psychopharmacology (Berl)       Date:  2004-08-13       Impact factor: 4.530

9.  Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.

Authors:  Mark J Millan; Sylvie Veiga; Sylvie Girardon; Mauricette Brocco
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

10.  Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization.

Authors:  Samantha E Yohn; Yumna Arif; Allison Haley; Guiseppe Tripodi; Younis Baqi; Christa E Müller; Noemi San Miguel; Mercè Correa; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2016-08-06       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.